Company news
Epsilon Healthcare Limited (ASX:EPN) news
Epsilon Healthcare Limited news releases on 6ix. Latest, Sep 9, 2021: Reinstatement to Official Quotation
Press releases — page 2
Reinstatement to Official Quotation
September 8, 2021
Epsilon Enters Exclusive Partnership with The Valens Company
September 8, 2021
Suspension from Official Quotation
September 8, 2021
Appendix 4D
August 31, 2021
Tetra Launches New Face to Face Clinic in Melbourne
August 18, 2021
Appointment of New Directors
August 1, 2021
Q2 2021 Quarterly Update and Appendix 4C
August 1, 2021
Clinical Trial Supply Agreement with MCRI
June 8, 2021
Over $1m R&D Tax Incentive Received
May 25, 2021
Q1 2021 Quarterly Update and Appendix 4C
April 27, 2021
Tetra Health Launches First Face to Face Clinic Site
March 10, 2021
Appendix 4E and Preliminary Final Report
February 26, 2021
Quarterly Update and Appendix 4C
January 29, 2021
Strategic Placement Completed
December 16, 2020
Proposed issue of Securities - THC
December 16, 2020
Strategic Update
December 10, 2020
Strategy Presentation - November 2020
November 1, 2020
Orders Successfully Obtained
September 22, 2020
Cleansing Prospectus
September 21, 2020
Response to ASX Accounts Query
September 15, 2020
Senior Executive Leadership Changes and Strategic Review
September 2, 2020
THC Global Quarterly Update & Appendix 4C
July 31, 2020
THC Global Completes Capital Raising
July 17, 2020
THC Global Canadian Operations & SPP Update
July 6, 2020
THC Global Medicinal Cannabis Sales Update
July 1, 2020
THC Global Signs Production Agreement with Medleaf
June 24, 2020
THC Global Completes $6.6 million Institutional Placement
June 22, 2020
THC Global Commences Production Deal with Cannatrek
June 14, 2020
THC Global Investor Presentation - June 2020
June 11, 2020
THC Global cannabis product available via prescription
May 20, 2020
THC Global acquires leading clinic network Tetra Health
May 12, 2020
THC Global Secures $4m Debt Facility
April 30, 2020
Medicinal Cannabis Australian Release and Export Update
April 21, 2020
Production commenced to support 6000 Australian Patients
March 2, 2020
Launch of Australian and International Medicines Supply
February 9, 2020
TGA GMP Manufacturing Licence Granted for Southport Facility
January 20, 2020
Product Supply Agreement Signed with MGC Pharma
January 19, 2020
First Medicinal Cannabis Processed at Southport Facility
December 3, 2019
THC Global Shareholder Update
November 19, 2019
Manufacturing Permit Received for Southport Facility
November 10, 2019
THC Global Builds New Zealand CBD Presence
October 20, 2019
Two Facilities Receive S4 and S8 Narcotics Licences
October 16, 2019
THC Global Corporate Presentation - Sept 2019
September 24, 2019
THC Global secures 24.6ha cannabis cultivation site
September 4, 2019
THC Global Southport Manufacturing Facility Licenced
July 8, 2019
THC Global Granted Manufacture Licence
June 12, 2019
Chairmans Address
May 28, 2019
THC Global Expands Cultivation & Export Licence Granted
May 14, 2019
THC Global Share Purchase Plan Update
April 17, 2019
THC Global Hydroponic Equipment Operations Update
April 16, 2019